{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:52:13Z","timestamp":1793332333452,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.bbi.2025.05.025","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T19:35:34Z","timestamp":1748374534000},"page":"92-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Plasma kynurenine pathway metabolite levels increase in depressed patients after antidepressant treatment"],"prefix":"10.1016","volume":"129","author":[{"given":"Romain","family":"Colle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6848-7009","authenticated-orcid":false,"given":"Kenneth","family":"Chappell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalil","family":"El Asmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"F\u00e8ve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Chanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis J.","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Verstuyft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Becquemont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Corruble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2025.05.025_b0005","doi-asserted-by":"crossref","unstructured":"Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet Lond Engl 2015;386:743\u2013800. doi: 10.1016\/S0140-6736(15)60692-4.","DOI":"10.1016\/S0140-6736(15)60692-4"},{"key":"10.1016\/j.bbi.2025.05.025_b0010","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaf9794","article-title":"Tryptophan\u2019s metabolites in exercise, inflammation, and mental health","volume":"357","author":"Cervenka","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.bbi.2025.05.025_b0015","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.3390\/cells10061548","article-title":"Neuroinflammation and the Kynurenine Pathway in CNS Disease: Molecular Mechanisms and Therapeutic Implications","volume":"10","author":"Mithaiwala","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.bbi.2025.05.025_b0020","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41380-019-0414-4","article-title":"The kynurenine pathway: a finger in every pie","volume":"25","author":"Savitz","year":"2020","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.bbi.2025.05.025_b0025","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/pcn.12944","article-title":"Peripheral tryptophan, serotonin, kynurenine, and their metabolites in major depression: A case-control study","volume":"74","author":"Colle","year":"2020","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.bbi.2025.05.025_b0030","article-title":"The tryptophan catabolite or kynurenine pathway in major depressive and bipolar disorder: A systematic review and meta-analysis","volume":"26","author":"Almulla","year":"2022","journal-title":"Brain Behav Immun - Health"},{"key":"10.1016\/j.bbi.2025.05.025_b0035","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.neubiorev.2018.05.031","article-title":"Role of Kynurenine pathway and its metabolites in mood disorders: A systematic review and meta-analysis of clinical studies","volume":"92","author":"Arnone","year":"2018","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.bbi.2025.05.025_b0040","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1038\/s41380-020-00951-9","article-title":"The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a meta-analysis of 101 studies","volume":"26","author":"Marx","year":"2021","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.bbi.2025.05.025_b0045","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neubiorev.2018.03.023","article-title":"Kynurenine pathway in depression: A systematic review and meta-analysis","volume":"90","author":"Ogyu","year":"2018","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.bbi.2025.05.025_b0050","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jad.2023.07.078","article-title":"The kynurenine pathway in major depressive disorder under different disease states: A systematic review and meta-analysis","volume":"339","author":"Ou","year":"2023","journal-title":"J Affect Disord"},{"key":"10.1016\/j.bbi.2025.05.025_b0055","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1038\/s41380-020-0645-4","article-title":"An integrated meta-analysis of peripheral blood metabolites and biological functions in major depressive disorder","volume":"26","author":"Pu","year":"2021","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.bbi.2025.05.025_b0060","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/wps.20260","article-title":"Treating major depressive episodes with antidepressants can induce or worsen metabolic syndrome: results of the METADAP cohort","volume":"14","author":"Corruble","year":"2015","journal-title":"World Psychiatry"},{"key":"10.1016\/j.bbi.2025.05.025_b0065","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.bbi.2025.05.025_b0070","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1080\/15622970801981606","article-title":"Outcomes in major depressive disorder: the evolving concept of remission and its implications for treatment","volume":"9","author":"Moller","year":"2008","journal-title":"World J Biol Psychiatry"},{"key":"10.1016\/j.bbi.2025.05.025_b0075","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1038\/sj.npp.1301131","article-title":"Report by the ACNP Task Force on Response and Remission in Major Depressive Disorder","volume":"31","author":"Rush","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbi.2025.05.025_b0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173615","article-title":"The human plasma-metabolome: Reference values in 800 French healthy volunteers; impact of cholesterol, gender and age","volume":"12","author":"Trabado","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bbi.2025.05.025_b0085","first-page":"393","article-title":"A comparison of parameters below the limit of detection in geochemical analyses by substitution methods","volume":"58","author":"Verbov\u0161ek","year":"2011","journal-title":"Mater Geoenviron"},{"key":"10.1016\/j.bbi.2025.05.025_b0090","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1146\/annurev.psych.093008.100356","article-title":"The Disaggregation of Within-Person and Between-Person Effects in Longitudinal Models of Change","volume":"62","author":"Curran","year":"2011","journal-title":"Annu Rev Psychol"},{"key":"10.1016\/j.bbi.2025.05.025_b0095","article-title":"Hair cortisol concentration across the peripartum period: Documenting changes and associations with depressive symptoms and recent adversity","volume":"9","author":"King","year":"2021","journal-title":"Compr Psychoneuroendocrinology"},{"key":"10.1016\/j.bbi.2025.05.025_b0100","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1037\/1082-989X.12.2.121","article-title":"Centering predictor variables in cross-sectional multilevel models: a new look at an old issue","volume":"12","author":"Enders","year":"2007","journal-title":"Psychol Methods"},{"key":"10.1016\/j.bbi.2025.05.025_b0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v067.i01","article-title":"Fitting Linear Mixed-Effects Models Using lme4","volume":"67","author":"Bates","year":"2015","journal-title":"J Stat Softw"},{"key":"10.1016\/j.bbi.2025.05.025_b0110","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1021\/acs.jproteome.7b00518","article-title":"Long-Term Stability of Human Plasma Metabolites during Storage at -80 \u00b0C","volume":"17","author":"Haid","year":"2018","journal-title":"J Proteome Res"},{"key":"10.1016\/j.bbi.2025.05.025_b0115","series-title":"C Reactive Protein","author":"Nehring","year":"2023"},{"key":"10.1016\/j.bbi.2025.05.025_b0120","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.bbi.2025.01.002","article-title":"Advancing precision psychiatry and targeted treatments: Insights from immunopsychiatry","volume":"125","author":"Miller","year":"2025","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.bbi.2025.05.025_b0125","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.bbi.2019.10.005","article-title":"Tryptophan metabolite concentrations in depressed patients before and after electroconvulsive therapy","volume":"83","author":"Ryan","year":"2020","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.bbi.2025.05.025_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41398-019-0507-5","article-title":"Metabolomic signature of exposure and response to citalopram\/escitalopram in depressed outpatients","volume":"9","author":"Bhattacharyya","year":"2019","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.bbi.2025.05.025_b0135","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.bbi.2020.01.011","article-title":"The relationship between plasma serotonin and kynurenine pathway metabolite levels and the treatment response to escitalopram and desvenlafaxine","volume":"87","author":"Sun","year":"2020","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.bbi.2025.05.025_b0140","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.pharep.2018.01.004","article-title":"Prolonged therapy with antidepressants increases hippocampal level of kynurenic acid and expression of Kat1 and Kat2 genes","volume":"70","author":"Kocki","year":"2018","journal-title":"Pharmacol Rep PR"},{"key":"10.1016\/j.bbi.2025.05.025_b0145","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00702-011-0668-8","article-title":"New insight into the antidepressants action: modulation of kynurenine pathway by increasing the kynurenic acid\/3-hydroxykynurenine ratio","volume":"119","author":"Kocki","year":"2012","journal-title":"J Neural Transm"},{"key":"10.1016\/j.bbi.2025.05.025_b0150","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.2147\/NDT.S305331","article-title":"Clinically Significant Changes in the 17- and 6-Item Hamilton Rating Scales for Depression: A STAR*D Report","volume":"17","author":"Rush","year":"2021","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.bbi.2025.05.025_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2025.106060","article-title":"Inflammatory markers associated with electroconvulsive therapy response in patients with depression: A meta-analysis","volume":"170","author":"Dellink","year":"2025","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.bbi.2025.05.025_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41398-017-0056-8","article-title":"Beta-defensin 1, aryl hydrocarbon receptor and plasma kynurenine in major depressive disorder: metabolomics-informed genomics","volume":"8","author":"Liu","year":"2018","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.bbi.2025.05.025_b0165","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1080\/15622975.2023.2169348","article-title":"Phase-and disorder-specific differences in peripheral metabolites of the kynurenine pathway in major depression, bipolar affective disorder and schizophrenia","volume":"24","author":"Brum","year":"2023","journal-title":"World J Biol Psychiatry"},{"key":"10.1016\/j.bbi.2025.05.025_b0170","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nri.2015.5","article-title":"The role of inflammation in depression: from evolutionary imperative to modern treatment target","volume":"16","author":"Miller","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.bbi.2025.05.025_b0175","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0006-8993(92)90852-Z","article-title":"Action of picolinic acid and structurally related pyridine carboxylic acids on quinolinic acid-induced cortical cholinergic damage","volume":"599","author":"Cockhill","year":"1992","journal-title":"Brain Res"},{"key":"10.1016\/j.bbi.2025.05.025_b0180","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/0306-4522(94)90438-3","article-title":"Picolinic acid blocks the neurotoxic but not the neuroexcitant properties of quinolinic acid in the rat brain: evidence from turning behaviour and tyrosine hydroxylase immunohistochemistry","volume":"61","author":"Beninger","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbi.2025.05.025_b0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-8993(94)90504-5","article-title":"Picolinic acid protects against quinolinic acid-induced depletion of NADPH diaphorase containing neurons in the rat striatum","volume":"668","author":"Kalisch","year":"1994","journal-title":"Brain Res"},{"key":"10.1016\/j.bbi.2025.05.025_b0190","doi-asserted-by":"crossref","first-page":"e865","DOI":"10.1038\/tp.2016.133","article-title":"An enzyme in the kynurenine pathway that governs vulnerability to suicidal behavior by regulating excitotoxicity and neuroinflammation","volume":"6","author":"Brundin","year":"2016","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.bbi.2025.05.025_b0195","first-page":"577","article-title":"Is the Enzyme ACMSD a Novel Therapeutic Target in Parkinson\u2019s Disease?","volume":"7","author":"Thirtamara-Rajamani","year":"2017","journal-title":"J Park Dis"},{"key":"10.1016\/j.bbi.2025.05.025_b0200","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.3390\/jcm11133622","article-title":"Identification of Genetic Variations in the NAD-Related Pathways for Patients with Major Depressive Disorder: A Case-Control Study in Taiwan","volume":"11","author":"Chen","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.bbi.2025.05.025_b0205","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.neuropharm.2012.03.009","article-title":"Actions of Xanthurenic Acid, a putative endogenous Group II metabotropic glutamate receptor agonist, on sensory transmission in the thalamus","volume":"66","author":"Copeland","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbi.2025.05.025_b0210","doi-asserted-by":"crossref","first-page":"17799","DOI":"10.1038\/srep17799","article-title":"Xanthurenic Acid Activates mGlu2\/3 Metabotropic Glutamate Receptors and is a Potential Trait Marker for Schizophrenia","volume":"5","author":"Fazio","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.bbi.2025.05.025_b0215","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/npp.2013.4","article-title":"Modulation of hippocampal synaptic transmission by the kynurenine pathway member xanthurenic acid and other VGLUT inhibitors","volume":"38","author":"Neale","year":"2013","journal-title":"Neuropsychopharmacol off Publ Am Coll Neuropsychopharmacol"},{"key":"10.1016\/j.bbi.2025.05.025_b0220","doi-asserted-by":"crossref","first-page":"6974","DOI":"10.3390\/ijms22136974","article-title":"A Role for Xanthurenic Acid in the Control of Brain Dopaminergic Activity","volume":"22","author":"Taleb","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bbi.2025.05.025_b0225","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s40265-017-0702-8","article-title":"Ketamine and Beyond: Investigations into the Potential of Glutamatergic Agents to Treat Depression","volume":"77","author":"Lener","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.bbi.2025.05.025_b0230","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s43440-020-00067-5","article-title":"Antidepressant-like effects of kynurenic acid in a modified forced swim test","volume":"72","author":"Tanaka","year":"2020","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.bbi.2025.05.025_b0235","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/s41386-020-0607-1","article-title":"Associations among peripheral and central kynurenine pathway metabolites and inflammation in depression","volume":"45","author":"Haroon","year":"2020","journal-title":"Neuropsychopharmacol off Publ Am Coll Neuropsychopharmacol"},{"key":"10.1016\/j.bbi.2025.05.025_b0240","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.bbi.2022.01.002","article-title":"Peripheral and central kynurenine pathway abnormalities in major depression","volume":"101","author":"Paul","year":"2022","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.bbi.2025.05.025_b0245","first-page":"e26 -","article-title":"Pretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: a proof of concept. Transl","volume":"1","author":"Kaddurah-Daouk","year":"2011","journal-title":"Psychiatry"},{"key":"10.1016\/j.bbi.2025.05.025_b0250","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.psychres.2016.11.044","article-title":"Clinical trial methodology to assess the efficacy\/effectiveness of long-acting antipsychotics: Randomized controlled trials vs naturalistic studies","volume":"247","author":"Fagiolini","year":"2017","journal-title":"Psychiatry Res"}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159125002028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159125002028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T20:47:06Z","timestamp":1759610826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159125002028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":50,"alternative-id":["S0889159125002028"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2025.05.025","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma kynurenine pathway metabolite levels increase in depressed patients after antidepressant treatment","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2025.05.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}